828
Participants
Start Date
October 15, 2012
Primary Completion Date
June 17, 2013
Study Completion Date
June 17, 2013
FF/VI 100/25 Inhalation Powder NDPI
Subjects randomized to the FF/VI Inhalation Powder Novel Dry Powder Inhaler (NDPI) arm will receive a single inhalation of 100 mcg FF and 25 mcg VI via NDPI every morning for 12 weeks.
Fluticasone Propionate/Salmeterol 250/50 Inhalation Powder ACCUHALER/DISKUS
Subjects randomized to the Fluticasone Propionate/Salmeterol Inhalation Powder ACCUHALER/DISKUS arm will receive a single inhalation of 250 mcg Fluticasone Propionate and 50 mcg Salmeterol via ACCUHALER/DISKUS once in the morning and once in the evening for 12 weeks.
Placebo Inhalation Powder NDPI
Subjects randomized to the Fluticasone Propionate/Salmeterol Inhalation Powder ACCUHALER/DISKUS arm will receive a single inhalation of placebo inhalation powder via NDPI every morning for 12 weeks.
Placebo Inhalation Powder ACCUHALER/DISKUS
Subjects randomized to the FF/VI Inhalation Powder NDPI arm will receive a single inhalation of placebo inhalation powder via ACCUHALER/DISKUS once in the morning and once in the evening for 12 weeks.
Salbutamol as needed
Salbutamol inhalation powder
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Hamburg
GSK Investigational Site, Charlotte
GSK Investigational Site, Orangeburg
GSK Investigational Site, Spartanburg
GSK Investigational Site, Gaffney
GSK Investigational Site, Union
GSK Investigational Site, Greenville
GSK Investigational Site, Easley
GSK Investigational Site, Seneca
GSK Investigational Site, Rock Hill
GSK Investigational Site, Hanover
GSK Investigational Site, Hanover
GSK Investigational Site, DeLand
GSK Investigational Site, Clearwater
GSK Investigational Site, Columbus
GSK Investigational Site, Woodbury
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Kharkiv
GSK Investigational Site, Normal
GSK Investigational Site, Neu-Isenburg
GSK Investigational Site, Bucharest
GSK Investigational Site, Coeur d'Alene
GSK Investigational Site, Renton
GSK Investigational Site, Ploieşti
GSK Investigational Site, Piteşti
GSK Investigational Site, Yaroslavl
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Râmnicu Vâlcea
GSK Investigational Site, Timișoara
GSK Investigational Site, Kursk
GSK Investigational Site, Cluj-Napoca
GSK Investigational Site, Ulyanovsk
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Brasov
GSK Investigational Site, Brasov
GSK Investigational Site, Bacau
GSK Investigational Site, Perm
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Kemerovo
GSK Investigational Site, Kemerovo
GSK Investigational Site, Vladivostok
GSK Investigational Site, Iași
GSK Investigational Site, Suceava
GSK Investigational Site, Brăila
GSK Investigational Site, Cottbus
GSK Investigational Site, Delitzsch
GSK Investigational Site, Dresden
GSK Investigational Site, Leipzg
GSK Investigational Site, Leipzig
GSK Investigational Site, Bucharest
GSK Investigational Site, Kiev
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
Lead Sponsor
GlaxoSmithKline
INDUSTRY